National and Kapodistrian University of Athens
Ο ρόλος της υποβιταμίνωσης Κ στην παθογένεια της οστεοπόρωσης σε παιδιά με ινώδη κυστική νόσο
Abstract
dc:descriptionImpaired vitamin K status has been reported in cystic fibrosis (CF) and is considered a newly emerged pathogenetic factor for reduced bone mineral density (BMD) in these patients.The aim of this study was to investigate the role of vitamin K deficiency in the development of osteopenia and / or osteoporosis in children and adolescents with CF and to evaluate the effectiveness of vitamin K supplementation in managing bone turnover abnormalities in these patients. We examined the status of vitamins K and D in relation to biochemical markers of bone metabolism and BMD in 20 children and adolescents with CF supplemented with vitamin D, but not with vitamin K. We repeated the laboratory tests in the same patients, after they had been supplemented with vitamin K in a single oral dose of 10 mg per week, for one year, and we compared the results before and after vitamin K supplementation. Results were also compared to a healthy control group of 25 children and adolescents. Ten of our CF patients had BMD z-score lower than -2.5 (n=5) or between -1 and -2.5 (n=5). Biochemical analysis of patients before vitamin K supplementation showed that values of osteoblastic activity markers, i.e., bone alkaline phosphatase (BAP), serum osteocalcin (Gla-OC), serum carboxy-terminal propeptide of type I procollagen (PICP), and serum aminoterminal propeptide of type I procollagen (PINP), were reduced in comparison with the control group (p<0.001, p=0.002, p=0.012, p<0.001, respectively). They also had lower serum levels of 25-hydroxy-vitamin D (250HD) and vitamin K (p<0.001, and p=0.021, respectively) as well as higher levels of undercaboxylated osteocalcin (Glu-OC), parathormone (PTH) and calcium to Creatinine ratio (Ca/Cr) (p<0.001, p=0.005, and p=0.017, respectively) compared with controls. Vitamin K intake was associated with an increase in levels of Gla-OC, PINP, and PICP (p=0.013, p<0.001, and p<0.001, respectively) and a decrease in levels of Glu-OC (p<0.001). In addition, PTH levels were lower after supplementation with vitamin K (p=0.020). No difference was found in BMD z-scores before and after vitamin K supplementation (p=0.935). Our data indicate that vitamin K supplementation in a dose of 10 mg per week may have a beneficial role in bone health in children with CF.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2006
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Stayrinadis, Ilias
- Σταυρινάδης, Ηλίας
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/24798